2021 Annual SRNT-E Conference

15th - 17th Sep 2021

Addresses / Patronages

Accordion Arrow

Greetings from the Federal Office of Public Health

I would like to wish you a very warm welcome for the 21st Annual Conference of the Society for Research on Nicotine and Tobacco. We were honoured to welcome you in Lausanne, Switzerland in 2020, unfortunately the conference could not take place. Nevertheless, we would like to welcome you virtually at the 21st SRNT-E Annual Conference 2021, organised by Unisanté, which is very active in tobacco control.

The theme of this year’s conference, “Innovative approaches to an old problem”, should entice to participate. Do we need more scientific evidence for an effective policy in tobacco control? Sometimes it seems to be necessary, because scientific facts can clash with other interests, especially when economic interests of the private sector are at stake. It is one of the reasons why Switzerland is second –to-last in terms of tobacco control in Europe. The results of the conference will therefore be crucial in helping the authorities to find innovative strategies to protect people from health problems associated with tobacco consumption.

Clearly, we need to develop new approaches to further reduce the number of smokers, especially among young people, and strive for a smoke-free world. During the last 10 years, we have had over 27% that is almost 2 million smokers, in Switzerland. Thus, tobacco consumption is one of the largest public health problems. Every hour, one person dies because of smoking, which corresponds to 15% of all deaths. Tobacco consumption causes many non-communicable diseases and is a major burden on public health and the national economy. The cost of medical treatment for these diseases in Switzerland amounts to CHF 1.7 billion per year. Moreover, we also need to add the costs of loss of earnings of 3.9 billion francs per year, when smokers fall ill and become incapacitated for work. 

In Switzerland, a new tobacco products’ law is currently under discussion in our Parliament. This new law will apply to all new tobacco and nicotine products.

I look forward to interesting discussions and valuable insights at the conference and hope that you will enjoy your stay in one of the most beautiful cities in Switzerland on the shores of the lovely Lake of Geneva.

Dr. Roland Charrière

Deputy Director of the Federal Office of Public Health

Greetings from the 'Ligue pulmonaire vaudoise'

Welcome to this 21st edition of the SRNT-E annual Conference!

As an actor of public health, our association is happy to support tobacco and nicotine research as a means of protecting our youth. Every day, our medical and social staff work with people suffering from lung disease. Our specialized team collaborates with pulmonologists to better use respiratory therapies for their patients, so they can have a better daily life. Shortness of breath makes it difficult to live! Climbing the stairs, going for a walk, all of these simple things become a challenge when lungs are damaged. Tobacco consumption and nicotine addiction are the main risk factors of lung disease in European countries. This is why we are glad to support this Conference and hope that all the studies presented and researches participating will give our Parliament members the information needed to strengthen tobacco regulation in Switzerland.

Stéphane Jeanneret

Director of Ligue pulmonaire vaudoise


Accordion Arrow

I. Clinical

Prof. Nancy Rigotti, Boston, USA View website

Building Tobacco Cessation Treatment into Health Care Systems: Leveraging the Opportunity of Hospital Admission

II. Public health

Prof. Ann McNeill, London, UK View website

England’s approach to e-cigarettes: managing the risks and benefits

III. Policy/Economy

Prof. Joachim Marti, Lausanne, Switzerland View website

The economics of tobacco regulation

IV. Basic Science/PreClinical

Prof. Rachel Tyndale , Toronto, Canada View website

Translating the rate of nicotine metabolism to Genetic Risk Scores: Across Ancestries and Application to Clinical Trial Data

Price Descriptions

Accordion Arrow

Fees from July 22, 2021

SRNT EUR member 180 Euros

SRNT member 230 Euros

Non SRNT member 320 Euros

Low and middle income countries 50 Euros

Student 50 Euros

French Track only - member SFT 80 Euros

French Track only - non member 130 Euros

French Track only - Unisanté/CHUV collaborator 80 Euros

Key Dates

Accordion Arrow

10th March 2021: Call for abstract and symposia submissions open

25th April 2021: Deadline for symposia submissions

--> Deadline extended to the 2nd of May 2021

9th May 2021: Deadline for oral/poster abstract submissions

--> Deadline extended to the 23rd of May 2021

30th June 2021: Deadline for abstract reviewing decisions

30th June 2021 : Early Bird registration

--> Deadline extended to 14th of July 2021

15th August 2021: Deadline for rapid response abstract (poster only)

--> Deadline extended to 31st of August 2021

September 15th-17th 2021: Conference

Funding and Sponsors

Accordion Arrow


This conference is organized without support from the industry (pharmaceutical, tobacco, e-cigarette,…). In a complex era of scientific debate on vaping and heated tobacco products, it is important to propose a conference completely independent and free from industry influence.